[1]
“Use of oral contraceptives, depot medroxyprogesterone acetate and intrauterine contraceptive devices and the risk of cancer”, J Obstet Gynaecol East Cent Africa, vol. 29, no. 1, pp. 11–16, Jun. 2017, doi: 10.59692/jogeca.v29i1.351.